Cargando…
Altered m(6)A modification is involved in up‐regulated expression of FOXO3 in luteinized granulosa cells of non‐obese polycystic ovary syndrome patients
The pathophysiology of polycystic ovary syndrome (PCOS) is characterized by granulosa cell (GC) dysfunction. m(6)A modification affects GC function in patients with premature ovarian insufficiency (POI), but the role of m(6)A modification in PCOS is unknown. The purpose of the prospective comparativ...
Autores principales: | Zhang, Shen, Deng, Wenli, Liu, Qiongyou, Wang, Peiyu, Yang, Wei, Ni, Wuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578862/ https://www.ncbi.nlm.nih.gov/pubmed/32869942 http://dx.doi.org/10.1111/jcmm.15807 |
Ejemplares similares
-
Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012) -
Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome
por: Xu, Renfeng, et al.
Publicado: (2021) -
The role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
por: Wang, Zhi, et al.
Publicado: (2021) -
Chitosan oligosaccharide improves ovarian granulosa cells inflammation and oxidative stress in patients with polycystic ovary syndrome
por: Xie, Qi, et al.
Publicado: (2023) -
Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome
por: Fu, Wenyan, et al.
Publicado: (2023)